LPCN vs ATOS
Comparison between Lipocine Inc (LPCN, Company) and Atossa Therapeutics Inc (ATOS, Company).
Both LPCN and ATOS are from the Healthcare sector.
5-Year PerformanceLPCN has outperformed ATOS, delivering a return of -36.8% compared to -52.2%
LPCN vs ATOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LPCN vs ATOS - Historical Returns
Returns include dividend reinvestment.
LPCN vs ATOS - Annual Returns (2012 - 2026)
Returns include dividend reinvestment.
| Year | LPCN | ATOS |
|---|---|---|
| 2026 | -70.88% | -78.75% |
| 2025 | +65.23% | -38.55% |
| 2024 | +70.62% | +0.97% |
| 2023 | -60.26% | +50.12% |
| 2022 | -63.50% | -69.63% |
| 2021 | -30.69% | +68.42% |
| 2020 | +224.58% | -40.25% |
| 2019 | -73.63% | +35.34% |
| 2018 | -62.21% | -68.52% |
| 2017 | -6.52% | -81.69% |
| 2016 | -70.79% | -73.89% |
| 2015 | +139.44% | -77.14% |
| 2014 | -35.46% | -37.00% |
| 2013 | -17.50% | -38.95% |
| 2012 | N/A | -18.75% |
LPCN vs ATOS Drawdown Comparison
The maximum drawdown for LPCN was -99.38%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The maximum drawdown for ATOS was -99.99%, occurring on Jun 17, 2026. This drawdown has not yet recovered.
The current LPCN drawdown is -99.26%. The current ATOS drawdown is -99.99%.
| Rank | LPCN | ATOS |
|---|---|---|
| #1 | -99.38% Sep 8, 2015 - Apr 6, 2026 | -99.99% Mar 19, 2013 - Jun 17, 2026 |
| #2 | -60.50% Oct 22, 2013 - Jul 16, 2015 | -23.85% Dec 11, 2012 - Jan 29, 2013 |
| #3 | -27.69% Aug 11, 2015 - Sep 8, 2015 | -20.00% Feb 12, 2013 - Mar 18, 2013 |
| #4 | -10.96% Jul 22, 2015 - Aug 10, 2015 | -15.63% Nov 8, 2012 - Dec 10, 2012 |
| #5 | N/A | -4.85% Feb 1, 2013 - Feb 5, 2013 |
| #6 | N/A | -1.89% Jan 29, 2013 - Jan 31, 2013 |
Correlation
Correlation between LPCN and ATOS is 0.69 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks